K

Kenneth Lundström

Nanotherapeutics (United States)

ORCID: 0000-0002-0580-5209

359 papers and 10.2k citations.

PubIndex Score57Top 43% · seniorHow it's scored

359Publications

10.2kTotal Citations

First publication: 1963First senior author: 1963

Top publicationsby citations

Viral Vectors for COVID-19 Vaccine Development

Kenneth Lundström|Viruses|2021

Cited by 92

Safety aspects related to recombinant protein expression from Semliki Forest virus vectors

Kenneth Lundström, Ernst‐Jürgen Schlaeger|Cytotechnology|2001

Cited by 7

Indexing the rest of 359 publications…